involved-field radiotherapy
1.92.6% of the patients were ECOG<1, 63.2% in stage Ⅰ+Ⅱ, 84.7% with IPI score 0-2 and 25% with B symptoms, 93.9% (368/392) of the patients received CTOP (containing THP) regimen chemotherapy and among them 28.5% (112/392) plus involved field radiotherapy.
